A Pilot Study to Evaluate the Efficacy and Safety of Neoadjuvant Chemoradiotherapy With Capecitabine, . . .

NCT01130701 · clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
OTHER
Sponsor class

Stopped Study never went beyond FDA application for an IND #. FDAA required institutional DSMC which this institution then lacked.

Conditions

Interventions

Sponsor

University of Massachusetts, Worcester